Get started
Applied DNA Sciences, Inc.Applied DNA Sciences, Inc.Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

APDN chart


Full chart

APDN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.33 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−11.9399 USD
Net income (FY)
‪−9.95 M‬ USD
Revenue (FY)
‪13.37 M‬ USD
Shares float
‪50.41 M‬
Beta (1Y)
6.14

Employees


Employees (FY)
55
Change (1Y)
−14 −20.29%
Revenue / Employee (1Y)
‪243.04 K‬ USD
Net income / Employee (1Y)
‪−180.86 K‬ USD

About Applied DNA Sciences, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
James A. Hayward
Website
adnas.com
Headquarters
Stony Brook
Founded
1983
FIGI
BBG000DGRCY6
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

APDN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of APDN is 0.1551 USD — it has decreased by −0.48% in the past 24 hours. Watch Applied DNA Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Applied DNA Sciences, Inc. stocks are traded under the ticker APDN.
APDN stock has fallen by −9.34% compared to the previous week, the month change is a −49.03% fall, over the last year Applied DNA Sciences, Inc. has showed a −99.08% decrease.
APDN reached its all-time high on Feb 2, 2004 with the price of 170,400.0094 USD, and its all-time low was 0.1462 USD and was reached on Nov 15, 2024. View more price dynamics on APDN chart.
See other stocks reaching their highest and lowest prices.
APDN stock is 9.80% volatile and has beta coefficient of 6.14. Track Applied DNA Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Applied DNA Sciences, Inc. there?
Today Applied DNA Sciences, Inc. has the market capitalization of ‪8.33 M‬, it has decreased by −5.06% over the last week.
Yes, you can track Applied DNA Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Applied DNA Sciences, Inc. is going to release the next earnings report on Dec 18, 2024. Keep track of upcoming events with our Earnings Calendar.
APDN earnings for the last quarter are 0.47 USD per share, whereas the estimation was −0.49 USD resulting in a 194.95% surprise. The estimated earnings for the next quarter are −0.34 USD per share. See more details about Applied DNA Sciences, Inc. earnings.
Applied DNA Sciences, Inc. revenue for the last quarter amounts to ‪798.00 K‬ USD, despite the estimated figure of ‪1.08 M‬ USD. In the next quarter, revenue is expected to reach ‪899.00 K‬ USD.
APDN net income for the last quarter is ‪1.88 M‬ USD, while the quarter before that showed ‪−4.47 M‬ USD of net income which accounts for 142.05% change. Track more Applied DNA Sciences, Inc. financial stats to get the full picture.
No, APDN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 55.00 employees. See our rating of the largest employees — is Applied DNA Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Applied DNA Sciences, Inc. EBITDA is ‪−13.98 M‬ USD, and current EBITDA margin is −71.75%. See more stats in Applied DNA Sciences, Inc. financial statements.
Like other stocks, APDN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Applied DNA Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Applied DNA Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Applied DNA Sciences, Inc. stock shows the sell signal. See more of Applied DNA Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.